A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer

AJ (Diane) van der Biessen, JA Gietema, Maja de Jonge, IME Desar, M W den Hollander, M Dudley, M Dunbar, R Hetman, C Serpenti, H (Hong) Xiong, RK Mittapalli, KM Timms, P Ansell, CK Ratajczak, SP Shepherd, CML van Herpen

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)828-835
Number of pages8
JournalInvestigational New Drugs
Volume36
Issue number5
DOIs
Publication statusPublished - 2018

Cite this